Who
Peter J. Arduini
Director
Company insider
Files Form 4 as: Director, Bristol-Myers Squibb; President and CEO, GE HealthCare Technologies; Senior Vice President, GE Aerospace; President & CEO, Integra LifeSciences Holdings; Corporate Vice President, Baxter International.
In numbers
- Trades disclosed
- 322
- Buys
- 1
- Sells
- 15
- Bought
- $500K
- Sold
- $44.3M
- Companies
- 5
- Companies where not an officer
- 1
- First trade
- 14 Mar 2006
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $35K560.897 at $62.40 | filing |
| 3 Sep 2026filed 4 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $445K6,303 at $70.56 | filing |
| 3 Sep 2026filed 4 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $445K6,303 at $70.56 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $430K6,043 at $71.23 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $390K5,472 at $71.23 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $430K6,043 at $71.23 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $390K5,472 at $71.23 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $35K607.428 at $57.62 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $35K607.43 at $57.62 | filing |
| 30 Apr 2026filed 30 Apr 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Bought | $250K4,169 at $59.93 | filing |
| 30 Apr 2026filed 30 Apr 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Bought | $250K4,169 at $59.93 | filing |
| 31 Mar 2026filed 2 Apr 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $35K577.082 at $60.65 | filing |
| 31 Mar 2026filed 2 Apr 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $35K577.08 at $60.65 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —49,120 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —129,140 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —129,140 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —49,120 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —74,908 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code F | $2.6M33,445 at $79.20 | filing |
| 12 Feb 2026filed 17 Feb 2026 | GEHC GE HealthCare TechnologiesMedical Devices | SEC FORM 4 Code A | —74,908 at $0.00 | filing |
News
Stock Traders Buy High Volume of Call Options on GE HealthCare Technologies (NASDAQ:GEHC)GEHC · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Peter J. Arduini; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.